Multi-mechanism. Full-dose.
Evidence-backed.
R3 combines Redensyl® (Givaudan), AnaGain™ (Mibelle Biochemistry), and Baicapil™ (Provital) at published clinical concentrations. 107 volunteers studied across three controlled protocols.
Clinical Integration
Standalone for mild-to-moderate AGA — 12-week minimum per Redensyl® protocol
PRP & Mesotherapy complement — non-cytotoxic formulation
Post-Transplant maintenance — Allantoin + Panthenol for scalp soothing
Cold-process at 20–30°C — preserves all bioactives (AnaGain™ spec: ≤60°C)
Rapid dry-down spray format — #1 driver of patient adherence
Partnership Benefits
Wholesale pricing — Clinic Pack (6) & Case (24)
Clinical tester kits — 12-week evaluation supply
Full scientific dossier with manufacturer brochure data
Patient fact sheets with brochure-sourced clinical endpoints
Co-branded marketing assets
Become an R3 Clinical Partner
Every claim sourced from published Givaudan, Mibelle, and Provital manufacturer data.